Ocular Tuberculosis: Unilateral, Asymmetric, and Varied in Presentation

Main Article Content

Lester H. Lambert, MD Carli M. Deitel, MD Caleb Choi, MD Brittany E. Powell, MD

Abstract

Tuberculosis is an infectious illness that can causes substantial morbidity and mortality globally. It is a “great masquerader,” as it can affect any organ system, in a variety of manifestations. The eye is no exception. Ocular tuberculosis can affect any part of the eye: the anterior segment, posterior segment, or adnexa. A common ocular manifestation is choroiditis. However, it may also present as panuveitis, retinal vasculitis, and neuroretinitis. Involvement of the posterior segment can produce substantial inflammation, increasing the risk of damage to the neurosensory retina, optic nerve, and surrounding tissues, resulting in irreversible vision loss. Thus, it is imperative to identify ocular tuberculosis as early as possible to initiate vision-saving treatment. Here, we present two cases of tuberculous chorioretinitis that demonstrate the wide spectrum of clinical presentation of posterior segment ocular involvement and its characteristic of being asymmetric or unilateral. These cases exemplify the importance of maintaining TB on a broad differential diagnosis of ocular inflammation.

Keywords: Ocular tuberculosis, Chorioretinitis, Mycobacterium, Vitritis, Neuroretinitis

Article Details

How to Cite
LAMBERT, Lester H. et al. Ocular Tuberculosis: Unilateral, Asymmetric, and Varied in Presentation. Medical Research Archives, [S.l.], v. 13, n. 2, feb. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6356>. Date accessed: 17 mar. 2025. doi: https://doi.org/10.18103/mra.v13i2.6356.
Section
Case Reports

References

1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991 Mar;72(1):1-6. doi: 10.1016/0041-3879(91)90017-m.
2. Biswas J, Badrinath SS. Ocular morbidity in patients with active systemic tuberculosis. Int Ophthalmol. 1995;19(5):293-8. doi:10.1007/BF00130924
3. Donahue HC Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol 1967;64742- 748
4. Islam SM, Tabbara KF. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol 2002;9239- 249
5. Zhang Y, et al. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis. PLoS One 2020;15:e0237995.
6. Alli HD, et al. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis. Surv Ophthalmol 2022;67:770-92.
7. Wang EW, Okwesili CN, Doub JB. Tuberculosis the great masquerader. ID Cases. Jun 2022; 29:e01541. doi: 10.1016/j.idcr.2022.e01541.
8. Thompson MJ, Albert DM. Ocular Tuberculosis. Arch Ophthalmol. 2005;123(6):844–849. doi:10.1001/archopht.123.6.844
9. Shah JS, Shetty N, Shah SK, Shah NK. Tubercular Uveitis with Ocular Manifestation as the First Presentation of Tuberculosis: A Case Series. J Clin Diagn Res. Mar 2016;10(3):NR01-3. doi:10.7860/JCDR/2016/16219.7375
10. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2019.
11. Filardo TD, et al. Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993–2019. Open Forum Infectious Diseases, Sep 2024;11(9):1-8. https://doi.org/10.1093/ofid/ofae476
12. Albert DM and Raven ML. Ocular Tuberculosis. Microbiol Spectr. 2016 Nov;4(6):10.1128. doi: 10.1128/microbiolspec.TNMI7-0001-2016
13. Alvarez GG, Roth VR, Hodge W. Ocular tuberculosis: diagnostic and treatment challenges. Int J Infect Dis. Jul 2009;13(4):432-5. doi:10.1016/j.ijid.2008.09.018
14. Kalia NP, Singh S, Hards K, et al. M. tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environments. Cell Rep. May 30 2023;42(5):112444. doi:10.1016/j.celrep.2023.112444
15. Srivastav S, Biswas A, Anand A. Interplay of niche and respiratory network in shaping bacterial colonization. J Biol Chem. Dec 9 2024;301(1):108052. doi:10.1016/j.jbc.2024.108052
16. Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. Nov 2012;119(11):2334-42. doi:10.1016/j.ophtha.2012.05.034
17. Carreno E, Portero A, Herreras JM, Calonge M, Foster CS. Distinctive clinical features of idiopathic versus infectious serpiginous choroidopathy. Ocul Immunol Inflamm. Dec 2012;20(6):448-52. doi:10.3109/09273948.2012.723236
18. Chawla R, Singh MK, Singh L, et al. Tubercular DNA PCR of ocular fluids and blood in cases of presumed ocular tuberculosis: a pilot study. Ther Adv Ophthalmol. Jan-Dec 2022;14:25158414221123522. doi:10.1177/25158414221123522
19. Putera I, Widodo E, Riasanti M, et al. Ocular tuberculosis with Mycobacterium tuberculosis DNA presence in ocular fluid: will post-COVID era bring a difference? Eye (Lond). Oct 2024;38(15):3027-3029. doi:10.1038/s41433-024-03200-3
20. Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. Sep-Oct 2009;17(5):351-5. doi:10.3109/09273940903168688
21. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health technology assessment. 2007;11(3)
22. Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. Jul 2009;116(7):1391-6. doi:10.1016/j.ophtha.2009.02.005
23. Arora D, Dhanashree B. Utility of smear microscopy and GeneXpert for the detection of Mycobacterium tuberculosis in clinical samples. Germs. Jun 2020;10(2):81-87. doi:10.18683/germs.2020.1188
24. Rasool G, Khan AM, Mohy-Ud-Din R, Riaz M. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert((R)) MTB/RIF assay. Int J Immunopathol Pharmacol. Jan-Dec 2019;33:2058738419827174. doi:10.1177/2058738419827174
25. Madhavan HN, Therese KL, Gunisha P, Jayanthi U, Biswas J. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease. Invest Ophthalmol Vis Sci. Mar 2000;41(3):822-5.
26. Zhang YK, Fu HY, Guan Y, Li YJ, Bai HZ. Concurrent tuberculous chorioretinitis with choroidal neovascularization and tuberculous meningitis: a case report. BMC Ophthalmol. Jun 12 2020;20(1):227. doi:10.1186/s12886-020-01504-y
27. Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. Nov 2017;28(6):545-551. doi:10.1097/ICU.0000000000000416
28. Saxena R, Singh D, Phuljhele S, et al. Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol. Dec 2021;69(12):3734-3739. doi:10.4103/ijo.IJO_3746_20